FDA OKs Sectra's cardiology imaging package:
This article was originally published in Clinica
Swedish IT and medical technology company Sectra has gained US FDA approval for its analysis package for cardiovascular imaging. The product provides physicians with analysis functions for quantifying arterial stenosis and overall heart function, including tools for quantitative coronary analysis and left ventricle analysis, says the Linkoping firm.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.